Vontobel Holding Ltd. Zai Lab LTD Transaction History

Vontobel Holding Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	SELL	$23.14 - $49.68 $106,652 - $228,975	-4,609 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$27.77 - $64.4 $127,991 - $296,819	4,609 New	4,609 $210,000
Q3 2021 Oct 29, 2021	SELL	$105.0 - $178.37 $816,900 - $1.39 Million	-7,780 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$125.11 - $180.0 $97,585 - $140,400	780 Added 11.14%	7,780 $1.38 Million
Q1 2021 May 11, 2021	BUY	$126.27 - $191.71 $56,821 - $86,269	450 Added 6.87%	7,000 $934,000
Q4 2020 Feb 12, 2021	BUY	$81.94 - $135.34 $536,707 - $886,477	6,550 New	6,550 $1.2 Million

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.61B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

Stay updated on Vontobel Holding Ltd. with notifications on news.